Clinical Trials Logo

Clinical Trial Summary

This study had a descriptive, retrospective, transversal character with quantitative approach, which aimed to delineate the social-economics profile of the asthmatic patients that used the health service available at the Care Nucleon Medical Integrate (NAMI)


Clinical Trial Description

The need of studies to develop programs of pharmaceutical attention for asthmatics was given because of the increase of incidence and prevalence of the disease in the population. This study had a descriptive, retrospective, transversal character with quantitative approach, which aimed to delineate the social-economics profile of the asthmatic patients that used the health service available at the Care Nucleon Medical Integrate (NAMI). The studied population was composed of 40 asthmatic patients who attended between April and May, during 2006. Data collection was performed through a semi-structured stereotypic questionnaire, with closed and opened questions. The age range of the interviewee between 0 to 5 years old represents the biggest percentage of patients, obtaining 60% of the answered questionnaires. According to social-economics conditions, 55% were illiterate or were learning to read, 75% were using some drug prescribed at NAMI, 72.5% deny completely the disease, 52.5% recognized the factors that triggered the asthmatic crisis and 55% said having often crisis. Seventy per cent (70%) of the interviewee showed some difficulty related to the use of the drugs; 47.5% have different problems related to the access to the medications. Through the analysis of the social-economics profile delineated of the asthmatics patients attended at NAMI, it could be revealed that the biggest part of the patients are people with little instruction, due to the social exclusion in which they are found; being the majority of them children of the female gender. ;


Study Design

Observational Model: Ecologic or Community, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT00722657
Study type Observational
Source Fortaleza University
Contact
Status Completed
Phase N/A
Start date April 2006
Completion date June 2006

See also
  Status Clinical Trial Phase
Completed NCT00901368 - FACTO Study (Foster® As Complete Treatment Option) Phase 4
Recruiting NCT01224977 - Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4. N/A
Terminated NCT01224964 - Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3 N/A
Not yet recruiting NCT06385964 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients Phase 1